Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - January 2013


Training ADME PK DM | Evaluation of ADMET Drug Properties in Drug Discovery and Development

22 Jan 2013 - 23 Jan 2013 - Sheraton Hotel Brussels Belgium



Bookmark and Share


Mondial Research has joined with strategic partners from the Biotech and Pharmaceutical Industry to bring together scientific experts to present and discuss recent advances towards accurately predicting human toxicities and screening earlier in the drug discovery process.


Agenda Topics
ADME Optimisation for Drug Design/Discovery
PK/PD
High Content Screening
Biobased Cellular Toxicity Assays
Metabolomics
MIP-DILI | IMI
IPS-derived Primary Cultures for Toxicity Assays
In Vitro QT Prolongation Assays with Cardiomyocytes
Genotoxicity
Biomarker Identification with Toxicogenomics
New Therapeutic Targets in Drug Design/Discovery
Pharmacogenomics and Drug Safety
Regulatory Issues in ADME
A Novel Human Hepatocyte Assay for Accurate Prediction of Severe DILI Drugs
Translational Investigation of Drug Disposition in Children
and much more...

Early Booking - £999 GBP for Conference Only if you book before October 31, 2012

Please contact cristinah@mondialresearchgroup.com for more info. You can also register online at the link above.



Further information
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Plant Compounds Fight Together Against Colon Cancer
Research shows treating colon cancer cells with curcumin, then silymarin is more effective than treatment with each individually.
New Centre Offers Ultra-Speed Protein Analysis
UW-Madison researchers to establish development centre for next-gen protein measurement technologies.
Drug Candidates Reduce Abnormal Protein Production
New drug candidates improve cell ability to catch miss-folded proteins that could cause deadly diseases.
Supercomputing and Drug Discovery
New biotech company uses supercomputer simulations to speed up drug discovery and biotech molecule development.
Preventing Breast Cancer with Hops
Study of hops extract suggests prevention of breast cancer through chemical pathway activation.
Treatment Advancement for Gaucher and Parkinson's Diseases
NIH scientists identify molecule that may act as a possible treatment of neurological diseases.
Biomunex Confirms Optimal Properties and Activity of BiXAb® Antibodies
Biomunex‘s Plug-and-Play bispecific antibodies demonstrated excellent in vitro properties and in vivo activity positively differentiating their BiXAb platform from competing formats.
Liquid Biopsy Predicts Colon Cancer Recurrence
Scientists have used a genetic test that spots bits of cancer-related DNA circulating in the blood to accurately predict the likelihood of the disease’s return in some — but not all — of a small group of patients with early-stage colon cancer.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!